check_circleStudy Completed

Contraception, Ovulation Inhibition, Contraceptives, Oral

Study to evaluate efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 21-day regimen

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
516
Trial Dates
August 2000 - April 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Yasminelle (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Multi-center, open, uncontrolled study to investigate the efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 21-day regimen for 26 cycles in 504 healthy female subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A